Frameshift mutations in rdxA and metronidazole resistance in North American Helicobacter pylori isolates

J Antimicrob Chemother. 2000 Nov;46(5):793-6. doi: 10.1093/jac/46.5.793.

Abstract

In Helicobacter pylori, the oxygen-insensitive nitroreductase RdxA is likely to activate metronidazole (Mtz) by reduction and formation of cytotoxic intermediates. Mutations in rdxA have been associated with Mtz resistance in H. pylori. In vitro Mtz susceptibilities of 17 randomly selected H. pylori isolates were determined by the agar dilution method. DNA sequence analysis of rdxA alleles of eight susceptible isolates (MIC range: 0.25-1.0 mg/L) and nine resistant isolates (MIC range: 16-256 mg/L) showed that six of nine Mtz-resistant H. pylori isolates contained insertion or deletion mutations ('indel' mutations). One isolate contained a substitution mutation at codon position 148 that resulted in the introduction of a premature stop codon. Creation of stop codons within the rdxA coding sequence by either frameshift or substitution mutations resulted in premature translation termination and expression of putatively truncated RdxA polypeptides.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Bacterial Proteins / genetics*
  • Codon, Terminator / genetics
  • Drug Resistance, Microbial / genetics
  • Frameshift Mutation / genetics*
  • Helicobacter pylori / drug effects*
  • Helicobacter pylori / enzymology
  • Helicobacter pylori / genetics
  • Humans
  • Metronidazole / pharmacology*
  • Nitroreductases / genetics*
  • North America
  • Sequence Analysis, DNA / methods

Substances

  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Codon, Terminator
  • Metronidazole
  • Nitroreductases